Moreover, to be consistent with the previous studies reported in luminal breast cancer and ovarian cancer,17, 18 we also observed that RASAL2 could modulate BCa cells stemness and EMT via MAPK pathway, in which the transcription factor SOX2 acted as an important bridge. Here, RASAL2 is linked to ovarian cancer.